Clinical Trials Directory

Trials / Completed

CompletedNCT00060905

An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
370 (planned)
Sponsor
Abbott · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the safety and effectiveness of Depakote ER compared to placebo in the treatment of bipolar disorder, manic or mixed type in adults.

Conditions

Interventions

TypeNameDescription
DRUGDivalproex Sodium (Depakote ER)

Timeline

Start date
2003-01-01
First posted
2003-05-16
Last updated
2006-08-04

Locations

18 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00060905. Inclusion in this directory is not an endorsement.